First Antibody Surveys Draw Fire for Quality, Bias
Some study authors use serology data to call for easing lockdowns, but critics push back.
Some study authors use serology data to call for easing lockdowns, but critics push back.
One of the many COVID-19 vaccines in development has protected an animal, rhesus macaques, from infection by the new coronavirus, scientists report.
Statistical models of infectious disease are vital for understanding where the COVID-19 pandemic is headed.
Long hours, high risk of infection, and crushing uncertainty about how the pandemic will progress have led to high anxiety among health care workers in Mexico.
Political support is building for regulators in the United States to embrace the controversial strategy of intentionally infecting volunteers with the virus that causes COVID-19 in order to test experimental vaccines.
The antimalarials used against COVID-19 can increase the risk of cardiac arrest. Doctors seek to minimize the danger.
The national government in Japan has been slow to push for widespread social distancing.
Sewage has the potential to serve as a cheap, noninvasive tool to warn against outbreaks.
The results from the first batch of COVID-19 related surveys have generated more controversy than clarity.
Scientists in Indonesia are exasperated at the country’s response to the COVID-19 pandemic.
In studying the impact of the coronavirus, clinicians trace a ferocious rampage through the body, from brain to toes.
The National Institutes of Health (NIH) and major drug companies announced a plan to stage clinical trials of the drugs and vaccines in a bid to address the COVID-19 crisis.